レスキュー吸入器の世界市場

レスキュー吸入器の世界市場は2030年までに281億米ドルに達する見込み

2024年に178億米ドルと推定されるレスキュー吸入器の世界市場は、2024年から2030年にかけてCAGR 7.9%で成長し、2030年には281億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである定量噴霧式吸入器は、CAGR 9.2％を記録し、分析期間終了までに122億米ドルに達すると予測されます。乾燥粉末吸入器セグメントの成長率は、分析期間中CAGR 7.1％と推定されます。

米国市場は48億米ドルと推定、中国はCAGR12.5％で成長予測

米国のレスキュー吸入器市場は、2024年に48億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに61億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは12.5%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.9%と7.6%と予測されています。欧州では、ドイツがCAGR 5.3%で成長すると予測されています。

世界の「レスキュー吸入器」市場- 主要動向と促進要因のまとめ

レスキュー吸入器は依然として世界の急性呼吸器疾患救済のライフラインか？

主に短時間作用型β作動薬（SABA）であるレスキュー吸入器は、急性喘息発作や、喘鳴、咳、息切れなどの突発的な呼吸器症状を即座に緩和する上で、依然として重要な役割を担っています。これらの吸入薬は即効性の気管支拡張薬であり、気道の筋肉を弛緩させ、数分以内に呼吸通路を開放することで効果を発揮します。長期的な喘息コントロール療法の進歩にもかかわらず、レスキュー吸入器は、特に小児、高齢者、監視の行き届かない患者において、緊急の呼吸器状況における最前線の防衛手段であり続けています。喘息や慢性閉塞性肺疾患（COPD）の世界の有病率の上昇に伴い、特に都市部や先進工業地域では、効果的で即効性のある吸入療法への需要が引き続き高まっています。レスキュー吸入器は救命だけでなく、喘息アクションプランやCOPD管理プロトコルの基礎となるものであり、呼吸器ケアの主役となっています。

吸入器テクノロジーはどのようにアクセシビリティ、デリバリー、患者のコンプライアンスを向上させているか？

技術の進歩は、レスキュー吸入器をより効率的で、使いやすく、デジタルに統合された医療機器へと変化させています。定量噴霧式吸入器（MDI）は、薬物送達の精度を高めるために、用量カウンターの改良、人間工学に基づいたデザイン、推進剤の革新によって進化してきました。ドライパウダー吸入器（DPI）は、協調動作が苦手な患者のために、呼吸で作動する代替品を提供しています。Bluetoothセンサーとコンパニオンモバイルアプリを組み込んだスマート吸入器は、現在、吸入パターン、投与頻度を追跡し、アドヒアランスと早期介入を確実にするための警告を発します。このような技術革新は、小児や慢性患者を管理する介護者やヘルスケアプロバイダーにとって特に価値があります。製薬会社はまた、新興市場や緊急対応環境向けに、熱に安定な製剤やコンパクトな機器設計にも注力しています。これらの開発により、治療効果が向上し、患者は呼吸器疾患をよりよくコントロールできるようになります。

レスキュー吸入器の利用を促進する患者層とヘルスケア環境は？

レスキュー吸入器は複数の人口統計で広く使用されているが、喘息、COPD、運動誘発性気管支痙攣の患者にとって最も重要です。小児では、特に学校や家庭環境において、アレルギー誘発性発作の第一選択薬として使用されることが多いです。呼吸器疾患を併存する高齢患者は、急性COPDエピソードを管理し、入院を最小限に抑えるためにレスキュー吸入器を使用しています。救急部、救急車、緊急治療施設では、レスキュー吸入器を即時介入のための必須在庫として管理しています。工場、建設現場、粉塵の多い産業における産業保健サービスでも、職場で誘発される呼吸器系の緊急事態に備えて常備しています。大気汚染、都市部のアレルゲン、気候による呼吸器系悪化因子の増加により、レスキュー吸入器の必要性はあらゆる年齢層、地域にわたって拡大しています。このような多様な使用環境は、急性呼吸器ケアにおけるかけがえのない役割を強調しています。

レスキュー吸入器世界市場の成長を促進しているものは？

レスキュー吸入器市場の成長の原動力は、呼吸器疾患の罹患率の上昇、吸入器デザインの技術革新、喘息やCOPDの自己管理に関する意識の高まりです。技術的には、スマート吸入器、呼吸作動メカニズム、次世代エアロゾル製剤が使いやすさと治療効果を高めています。最終用途の観点からは、喘息とCOPDの有病率の拡大（特に中低所得国）が引き続き需要を押し上げています。学校ベースの喘息プログラム、職場の緊急用キット、遠隔医療による呼吸モニタリングなどの採用が増加し、より広範なアクセスとアドヒアランスを支えています。ジェネリック医薬品やOTC医薬品の規制当局による承認により、これらの製品はより手頃な価格で入手しやすくなっています。さらに、公害の急増や季節性アレルゲンなどの環境変化は、吸入器の使用頻度と緊急性を高めています。これらの要因が相まって、レスキュー吸入器に対する世界の需要は、臨床現場と地域社会の両方で力強く伸びています。

セグメント

製品タイプ（定量噴霧式吸入器、ドライパウダー吸入器、ネブライザー、ソフトミスト吸入器、その他の製品タイプ）、適応症（喘息、COPD、アレルギー性鼻炎、肺動脈性肺高血圧症、その他の適応症）、患者タイプ（成人、小児）、形態（カプセル、溶液、懸濁液、その他の形態）、エンドユーザー（ホームケア設定、病院＆クリニック）

調査対象企業の例（全48件）

• 3M
• Apotex Inc.
• AstraZeneca
• Boehringer Ingelheim
• Chiesi Farmaceutici
• Cipla
• Dr. Reddy's Laboratories
• GlaxoSmithKline（GSK）
• Hikma Pharmaceuticals
• Lupin Pharmaceuticals
• Merck & Co., Inc.
• Mundipharma
• Mylan
• Novartis
• Orion Corporation
• Sandoz（a Novartis division）
• Sun Pharmaceutical Industries
• Teva Pharmaceutical Industries
• Vectura Group
• Viatris Inc.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。我々の16,491以上のレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Rescue Inhalers Market to Reach US$28.1 Billion by 2030

The global market for Rescue Inhalers estimated at US$17.8 Billion in the year 2024, is expected to reach US$28.1 Billion by 2030, growing at a CAGR of 7.9% over the analysis period 2024-2030. Metered Dose Inhalers, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$12.2 Billion by the end of the analysis period. Growth in the Dry Powder Inhalers segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.8 Billion While China is Forecast to Grow at 12.5% CAGR

The Rescue Inhalers market in the U.S. is estimated at US$4.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.1 Billion by the year 2030 trailing a CAGR of 12.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 7.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.

Global "Rescue Inhalers" Market - Key Trends & Drivers Summarized

Are Rescue Inhalers Still The Lifeline For Acute Respiratory Relief Worldwide?

Rescue inhalers, primarily short-acting beta-agonists (SABAs), remain critical in providing immediate relief from acute asthma attacks and other sudden respiratory symptoms such as wheezing, coughing, and shortness of breath. These inhalers are fast-acting bronchodilators that work by relaxing airway muscles and opening up breathing passages within minutes. Despite advances in long-term asthma control therapies, rescue inhalers continue to be the frontline defense in emergency respiratory situations, especially in pediatric, elderly, and under-monitored patients. As the global prevalence of asthma and chronic obstructive pulmonary disease (COPD) rises, particularly in urban and industrialized regions, the demand for effective, rapid-response inhalation therapies remains robust. Rescue inhalers are not only life-saving but also foundational to asthma action plans and COPD management protocols, making them a mainstay in respiratory care.

How Are Inhaler Technologies Improving Accessibility, Delivery, And Patient Compliance?

Technological advancements are transforming rescue inhalers into more efficient, user-friendly, and digitally integrated medical devices. Metered-dose inhalers (MDIs) have evolved with improved dose counters, ergonomic designs, and propellant innovations to enhance drug delivery precision. Dry powder inhalers (DPIs) offer breath-actuated alternatives for patients who struggle with coordination. Smart inhalers embedded with Bluetooth sensors and companion mobile apps now track inhalation patterns, dosage frequency, and trigger alerts to ensure adherence and early intervention. These innovations are particularly valuable for caregivers and healthcare providers in managing pediatric and chronic patients. Pharmaceutical companies are also focusing on heat-stable formulations and compact device designs for emerging markets and emergency response settings. These developments are collectively improving treatment efficacy and empowering patients with better control over their respiratory conditions.

Which Patient Demographics And Healthcare Settings Drive Rescue Inhaler Utilization?

Rescue inhalers are widely used across multiple demographics, but they are most critical for patients with asthma, COPD, and exercise-induced bronchospasm. Pediatric populations often rely on them as first-line relief for allergy-induced attacks, especially in school and home environments. Elderly patients with comorbid respiratory conditions use rescue inhalers to manage acute COPD episodes and minimize hospitalizations. Emergency departments, ambulances, and urgent care facilities maintain rescue inhalers as essential stock for immediate intervention. Occupational health services in factories, construction sites, and high-dust industries also keep them on hand for workplace-triggered respiratory emergencies. The rise in air pollution, urban allergens, and climate-induced respiratory aggravators is expanding the need for rescue inhalers across all age groups and geographies. These diverse use environments underscore their irreplaceable role in acute respiratory care.

What’s Fueling Growth In The Global Rescue Inhalers Market?

The growth in the rescue inhalers market is driven by rising respiratory disease incidence, technological innovation in inhaler design, and increased awareness around asthma and COPD self-management. Technologically, smart inhalers, breath-actuated mechanisms, and next-gen aerosol formulations are enhancing usability and therapeutic effectiveness. From an end-use perspective, expanding asthma and COPD prevalence-especially in low- and middle-income countries-continues to push volume demand. Increased adoption of school-based asthma programs, workplace emergency kits, and telehealth respiratory monitoring are supporting broader access and adherence. Regulatory approvals of generic rescue inhalers and OTC options are making these products more affordable and accessible. Additionally, environmental changes such as pollution spikes and seasonal allergens are increasing both the frequency and urgency of inhaler use. Together, these factors are sustaining strong and growing global demand for rescue inhalers in both clinical and community-based settings.

SCOPE OF STUDY:

The report analyzes the Rescue Inhalers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers, Other Product Types); Indication (Asthma, COPD, Allergic Rhinitis, Pulmonary Arterial Hypertension, Other Indications); Patient Type (Adult, Pediatric); Form (Capsules, Solution, Suspension, Other Forms); End-User (Home Care Settings, Hospitals & Clinics)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

• 3M
• Apotex Inc.
• AstraZeneca
• Boehringer Ingelheim
• Chiesi Farmaceutici
• Cipla
• Dr. Reddy's Laboratories
• GlaxoSmithKline (GSK)
• Hikma Pharmaceuticals
• Lupin Pharmaceuticals
• Merck & Co., Inc.
• Mundipharma
• Mylan
• Novartis
• Orion Corporation
• Sandoz (a Novartis division)
• Sun Pharmaceutical Industries
• Teva Pharmaceutical Industries
• Vectura Group
• Viatris Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Rescue Inhalers - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Asthma and COPD Propels Global Demand for Fast-Acting Rescue Inhalers
  • Increased Awareness Campaigns and Early Diagnosis Efforts Drive Inhaler Prescriptions
  • Innovation in Breath-Activated and Dose-Tracking Inhaler Devices Improves Patient Adherence
  • Wider Insurance Coverage and Public Healthcare Access Expand Treatment Availability
  • Introduction of Generic Alternatives Lowers Cost and Expands Access in Emerging Markets
  • Rise in Air Pollution and Allergen Exposure Sustains Chronic Respiratory Illness Burden
  • Digital Integration With Mobile Apps Enhances Usage Tracking and Clinical Monitoring
  • Growing Pediatric and Geriatric Use Cases Drive Market Segmentation Opportunities
  • Partnerships Between Pharma and Telehealth Platforms Expand Digital Distribution
  • Regulatory Support for OTC Asthma Medications Fuels Retail-Based Inhaler Access
  • Clinical Advancements in Combination Therapies Strengthen Competitive Product Portfolios
  • Shortage of Rescue Medications in Remote Regions Presents Public Health Challenges
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Rescue Inhalers Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Rescue Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Rescue Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Rescue Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Metered Dose Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Metered Dose Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Metered Dose Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Dry Powder Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Dry Powder Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Dry Powder Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Nebulizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Nebulizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Nebulizers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Soft Mist Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Soft Mist Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Soft Mist Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Asthma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for COPD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for COPD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for COPD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Allergic Rhinitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Allergic Rhinitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Allergic Rhinitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Pulmonary Arterial Hypertension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Pulmonary Arterial Hypertension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Pulmonary Arterial Hypertension by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Adult by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Pediatric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Solution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Solution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Solution by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Suspension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Suspension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Suspension by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Other Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: World 15-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 59: USA Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: USA Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: USA 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 62: USA Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: USA Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: USA 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 65: USA Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: USA Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: USA 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 68: USA Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: USA Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: USA 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 71: USA Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: USA Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: USA 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 74: Canada Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Canada Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Canada 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 77: Canada Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Canada Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Canada 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 80: Canada Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Canada Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Canada 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 83: Canada Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Canada Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Canada 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 86: Canada Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Canada Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Canada 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• JAPAN
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 89: Japan Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Japan Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Japan 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 92: Japan Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Japan Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Japan 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 95: Japan Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Japan Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Japan 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 98: Japan Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Japan Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Japan 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 101: Japan Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Japan Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Japan 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• CHINA
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 104: China Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: China Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: China 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 107: China Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: China Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: China 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 110: China Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: China Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: China 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 113: China Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: China Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: China 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 116: China Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: China Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: China 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• EUROPE
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 119: Europe Recent Past, Current & Future Analysis for Rescue Inhalers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 120: Europe Historic Review for Rescue Inhalers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Europe 15-Year Perspective for Rescue Inhalers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 122: Europe Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Europe Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Europe 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 125: Europe Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Europe Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Europe 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 128: Europe Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Europe Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Europe 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 131: Europe Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Europe Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Europe 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 134: Europe Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Europe Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Europe 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• FRANCE
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 137: France Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: France Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: France 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 140: France Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: France Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: France 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 143: France Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: France Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: France 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 146: France Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: France Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: France 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 149: France Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: France Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: France 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• GERMANY
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 152: Germany Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Germany Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Germany 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 155: Germany Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Germany Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Germany 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 158: Germany Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Germany Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Germany 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 161: Germany Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Germany Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Germany 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 164: Germany Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Germany Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Germany 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 167: Italy Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Italy Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Italy 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 170: Italy Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Italy Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Italy 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 173: Italy Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Italy Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Italy 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 176: Italy Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Italy Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Italy 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 179: Italy Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Italy Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Italy 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 182: UK Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: UK Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: UK 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 185: UK Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: UK Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: UK 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 188: UK Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: UK Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: UK 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 191: UK Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: UK Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: UK 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 194: UK Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: UK Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: UK 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 197: Spain Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Spain Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Spain 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 200: Spain Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Spain Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Spain 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 203: Spain Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Spain Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Spain 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 206: Spain Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Spain Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Spain 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 209: Spain Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Spain Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Spain 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 212: Russia Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Russia Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Russia 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 215: Russia Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Russia Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Russia 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 218: Russia Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Russia Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Russia 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 221: Russia Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Russia Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Russia 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 224: Russia Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Russia Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Russia 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 227: Rest of Europe Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Europe Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Rest of Europe 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 230: Rest of Europe Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Europe Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Europe 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Europe Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Europe Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Europe 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Europe Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Europe Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Europe 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Europe Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Europe Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Europe 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 242: Asia-Pacific Recent Past, Current & Future Analysis for Rescue Inhalers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 243: Asia-Pacific Historic Review for Rescue Inhalers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Asia-Pacific 15-Year Perspective for Rescue Inhalers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 245: Asia-Pacific Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Asia-Pacific Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Asia-Pacific 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 248: Asia-Pacific Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Asia-Pacific Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Asia-Pacific 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 251: Asia-Pacific Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Asia-Pacific Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Asia-Pacific 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 254: Asia-Pacific Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Asia-Pacific Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Asia-Pacific 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 257: Asia-Pacific Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Asia-Pacific Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Asia-Pacific 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 260: Australia Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Australia Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Australia 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 263: Australia Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Australia Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Australia 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 266: Australia Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Australia Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Australia 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 269: Australia Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Australia Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Australia 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 272: Australia Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Australia Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Australia 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• INDIA
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 275: India Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: India Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: India 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 278: India Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: India Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: India 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 281: India Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: India Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: India 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 284: India Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: India Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: India 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 287: India Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: India Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: India 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 290: South Korea Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: South Korea Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: South Korea 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 293: South Korea Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: South Korea Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: South Korea 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 296: South Korea Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: South Korea Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: South Korea 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 299: South Korea Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: South Korea Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: South Korea 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 302: South Korea Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: South Korea Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: South Korea 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 305: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Asia-Pacific Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Asia-Pacific 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Asia-Pacific Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Asia-Pacific 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Asia-Pacific Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Asia-Pacific 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 314: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Asia-Pacific Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Asia-Pacific 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 317: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Asia-Pacific Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Rest of Asia-Pacific 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 320: Latin America Recent Past, Current & Future Analysis for Rescue Inhalers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 321: Latin America Historic Review for Rescue Inhalers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Latin America 15-Year Perspective for Rescue Inhalers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 323: Latin America Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Latin America Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Latin America 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 326: Latin America Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Latin America Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Latin America 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 329: Latin America Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Latin America Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Latin America 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 332: Latin America Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Latin America Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Latin America 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 335: Latin America Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Latin America Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Latin America 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 338: Argentina Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Argentina Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Argentina 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 341: Argentina Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Argentina Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Argentina 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 344: Argentina Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Argentina Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Argentina 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 347: Argentina Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Argentina Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Argentina 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 350: Argentina Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Argentina Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Argentina 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 353: Brazil Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Brazil Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Brazil 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 356: Brazil Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Brazil Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Brazil 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 359: Brazil Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Brazil Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Brazil 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 362: Brazil Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Brazil Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Brazil 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 365: Brazil Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Brazil Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Brazil 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 368: Mexico Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Mexico Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: Mexico 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 371: Mexico Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Mexico Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: Mexico 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 374: Mexico Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Mexico Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Mexico 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 377: Mexico Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Mexico Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Mexico 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 380: Mexico Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Mexico Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Mexico 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 383: Rest of Latin America Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Latin America Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Latin America 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 386: Rest of Latin America Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Latin America Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Latin America 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 389: Rest of Latin America Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Latin America Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Rest of Latin America 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 392: Rest of Latin America Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Latin America Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Rest of Latin America 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 395: Rest of Latin America Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Rest of Latin America Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Rest of Latin America 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 398: Middle East Recent Past, Current & Future Analysis for Rescue Inhalers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 399: Middle East Historic Review for Rescue Inhalers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Middle East 15-Year Perspective for Rescue Inhalers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 401: Middle East Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Middle East Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Middle East 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 404: Middle East Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Middle East Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 406: Middle East 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 407: Middle East Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Middle East Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 409: Middle East 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 410: Middle East Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Middle East Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 412: Middle East 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 413: Middle East Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Middle East Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 415: Middle East 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 416: Iran Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 417: Iran Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 418: Iran 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 419: Iran Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 420: Iran Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 421: Iran 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 422: Iran Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 423: Iran Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 424: Iran 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 425: Iran Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 426: Iran Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 427: Iran 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 428: Iran Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 429: Iran Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 430: Iran 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 431: Israel Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 432: Israel Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 433: Israel 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 434: Israel Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 435: Israel Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 436: Israel 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 437: Israel Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 438: Israel Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 439: Israel 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 440: Israel Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 441: Israel Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 442: Israel 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 443: Israel Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 444: Israel Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 445: Israel 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 446: Saudi Arabia Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 447: Saudi Arabia Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 448: Saudi Arabia 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 449: Saudi Arabia Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 450: Saudi Arabia Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 451: Saudi Arabia 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 452: Saudi Arabia Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 453: Saudi Arabia Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 454: Saudi Arabia 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 455: Saudi Arabia Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 456: Saudi Arabia Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 457: Saudi Arabia 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 458: Saudi Arabia Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 459: Saudi Arabia Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 460: Saudi Arabia 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 461: UAE Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 462: UAE Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 463: UAE 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 464: UAE Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 465: UAE Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 466: UAE 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 467: UAE Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 468: UAE Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 469: UAE 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 470: UAE Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 471: UAE Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 472: UAE 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 473: UAE Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 474: UAE Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 475: UAE 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 476: Rest of Middle East Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 477: Rest of Middle East Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 478: Rest of Middle East 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 479: Rest of Middle East Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 480: Rest of Middle East Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 481: Rest of Middle East 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 482: Rest of Middle East Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 483: Rest of Middle East Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 484: Rest of Middle East 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 485: Rest of Middle East Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 486: Rest of Middle East Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 487: Rest of Middle East 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 488: Rest of Middle East Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 489: Rest of Middle East Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 490: Rest of Middle East 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• AFRICA
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 491: Africa Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 492: Africa Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 493: Africa 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 494: Africa Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 495: Africa Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 496: Africa 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 497: Africa Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 498: Africa Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 499: Africa 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 500: Africa Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 501: Africa Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 502: Africa 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 503: Africa Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 504: Africa Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 505: Africa 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030

IV. COMPETITION